• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Incorporating a Multiple Modality Approach to Achieve Optimal Results


Jill Waibel, MD, discusses her success with a multimodal approach to meet the needs of aesthetic patients. She shares her preferred combinations of lasers for specific treatments and offers solutions to challenges practices face, including the selection of lasers, adapting schedules and patient expectations, and choosing a laser manufacturer who can truly serve as a partner.

Presented by: Jill Waibel, MD

Dr. Waibel practices as a Board Certified Dermatologist specializing in medical dermatology, cutaneous laser surgery and cosmetic dermatology for all ages. She is based at Miami Dermatology and Laser Institute in Miami, Florida where she operates as Medical Director and Owner.

In addition to her private practice, Dr. Waibel is the Subsection Chief of Dermatology at Baptist Hospital and the Medical Director of Miami Cancer Institute’s Multidisciplinary Skin Cancer Clinic. She also serves as a Clinical Voluntary Assistant Professor at the University of Miami.

Globally, Dr. Waibel is a world-recognized leader and innovator in dermatologic laser surgery. She lectures all over the world to train fellow physicians and help further the field of dermatology. In her own practice, she has over 65 laser devices for both medical and cosmetic cutaneous applications. Dr. Waibel is also active in basic science clinical trials at the University of Miami and has a robust clinical trials division, Miami Dermatology and Research. Her research department has a broad and continuous rotation of new pharmaceutical and medical device trials including phases 2, 3, and 4. She has also represented and advised several companies in bringing them through FDA approval.


Related Videos
© 2024 MJH Life Sciences

All rights reserved.